RTW Biotech Opportunities (LSE:RTW) Altman Z-Score


LSE:RTW RTW Biotech Opportunities Ltd LSE:RTW
36 GF Score
Price $2.33
! 2 Warning Signs
View Full Analysis

What is RTW Biotech Opportunities Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Altman Z-Score does not apply to banks and insurance companies.

LSE:RTW
36GF Score
RTW Biotech Opportunities Ltd LSE:RTW
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RTW Biotech Opportunities Business Description

Address St Julian’s Avenue, 1st Floor, Royal Chambers, St Peter Port, GGY, GY1 3JX
RTW Biotech Opportunities Ltd is a life sciences and investment fund focused on identifying transformative assets with high growth potential across the biopharma and medtech sectors. It is powering medical breakthroughs that have the potential to transform the wellbeing of people around the world. Its portfolio includes Neurology, Oncology, Inflammation, Cardiovascular, Metabolic, Pulmonary, Ophthalmology, Rare Disease, and Other. Geographically it operates in USA & Canada, the Rest of World, and UK & EU, with the majority of the revenue deriving from USA & Canada.
36GF Score

Get the complete analysis for LSE:RTW

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.33
Price